
corticosteroid therapy amyloid nephrotic syndrome . 
  results treatment prolonged adrenal corticosteroids 26 
adults amyloid nephrotic syndrome presented . eight subjects 
observed series, 18 additional cases summarized 
literature . twenty-two patients male four 
female . diagnosis established renal biopsy 19 instances 
autopsy others, 18 patients considered 
primary amyloidosis 8, secondary amyloidosis . 
  majority subjects died renal failure average 
survival onset disease 17.6 months . renal disease 
indistinguishable seen forms nephrotic 
syndrome, possible exceptions (a) high incidence 
purpuric skin lesions, (b) low negligible incidence hypertension 
(at times actual hypotension prominent), (c) rapid 
inexorable progression azotemia despite persistence clinical 
biochemical characteristics nephrotic syndrome . amyloidosis 
found percutaneous renal biopsy 12 per cent 83 adults 
nephotic syndrome . 
  corticosteroids appear affect progress disease 
neither beneficial detrimental . view high 
incidence deleterious side effects prolonged corticosteroid 
therapy availability potent diuretic agents may 
helpful relieving edema disorder, felt 
corticosteroids contraindicated treatment amyloid 
nephrotic syndrome . 
